ARway.ai Unveils Patent-Pending AI-powered 3D Digital Twin Floor Plan Generation Technology to Capture a Share of the $44 Billion Indoor Navigation Market

life science Investing News

Pharmaceutical Investing

Pharma Market Forecast: 3 Top Trends That Will Affect Pharma in 2023

Pharma stocks retreated in 2022 as the market faced challenges. Will the sector become a safe haven for investors again in 2023?

Latest Articles
Genetics Investing

Genetics Stocks: 5 Biggest Companies in 2023

Pharmaceutical Investing

Why Consider Investing in Pharmaceutical Stocks? (Updated 2023)

Pharmaceutical Investing

5 Biggest Pharmaceutical ETFs in 2023

Company Profiles
BCT:CA

BriaCell

Developing Personalized Off-The-Shelf Immunotherapy Treatments for Cancer Patients

SILO:CNX

Silo Wellness

Psychedelic Healing Right Now & Pharmaceutical Biotech

NSP:CA

Naturally Splendid Enterprises

Developing and Manufacturing Plant-Based Products

CEO Interviews
Biotech Investing

Eco-friendly Keystone Gummies Gaining Market Traction, CEO Says

Pharmaceutical Investing

Trip to Treatment: Lobe Sciences CEO Touts Targeted Low Dosing for Better Patient Outcomes

Trending
Genetics Investing

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2023

Genetics Investing

5 US Anti-aging Stocks (Updated 2023)

Life Science Investing

Plant-based Food Stocks: 10 Biggest Companies in 2023

Press Releases
Life Science Investing

Eupraxia Pharmaceuticals Reports Fourth Quarter and 2022 Financial Results

Emerging Tech Investing

Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection

Editors' Picks
Biotech Investing

Biotech Market Forecast: 3 Top Trends That Will Affect Biotech in 2023

Psychedelics Investing

Psychedelics Market Forecast: 3 Top Trends That Will Affect Psychedelics in 2023

Psychedelics Investing

Psychedelics Market 2022 Year-End Review

Don't Miss
Biotech Investing

Bristol Myers Squibb Receives European Commission Approval of Sotyktu , a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

Pharmaceutical Investing

KEYTRUDA® Plus Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma, Regardless of Mismatch Repair Status

Medical Device Investing

Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies

Medical Device Investing

Danaher Schedules First Quarter 2023 Earnings Conference Call

Medical Device Investing

Knight Therapeutics Inc. ranks on The Globe and Mail's fourth-annual Women Lead Here benchmark of executive gender diversity

Medical Device Investing

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Medical Device Investing

Medtronic Announces Pricing of $2.0 Billion of Senior Notes

Biotech Investing

Aptose Reports Results for the Fourth Quarter and Full Year 2022

Medical Device Investing

Seeking Answers About Transgender Heart Health

Pharmaceutical Investing

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Oak Street Health , Seagen Inc. , Provention Bio Inc. , Kimball International, Inc.

MARKETS

Markets
TSX19657.53+32.79
TSXV620.59+10.27
DOW32394.25-37.83
S&P 5003971.27-6.26
NASD11716.08-52.76
ASX6962.00+6.80

COMMODITIES

Commodities
Gold1974.01+16.05
Silver23.33+0.21
Copper4.08-0.01
Palladium1713.170.00
Platinum1087.260.00
Oil73.68+0.48
Heating Oil2.64-0.01
Natural Gas2.01-0.02

DOWNLOAD FREE REPORTS

EV Outlook 2023

2023 Lithium Outlook: Australia Edition

2023 Graphite Outlook: Australia Edition

2023 Battery Metals Outlook: Australia Edition

2023 Cobalt Outlook: Australia Edition

Browse more resource reports ≫

NEW! 2023 Tech Outlook Report

NEW! 2023 Cleantech Outlook Report

Emerging Tech Outlook 2023

NEW! 2023 AI Outlook Report

NEW! 2023 Crypto Outlook Report

Browse more technology reports ≫

NEW! 2023 Pharmaceuticals Outlook Report.

FREE 2023 Psychedelics Investor Report

NEW! 2023 Biotech Outlook Report.

NEW! 2023 Life Science Outlook Report.

Start Here – Investing in Pharma

Browse more life science reports ≫

BROWSE COMPANIES BY SECTOR

×